Author:
Smith Yoland,Wichmann Thomas,Factor Stewart A,DeLong Mahlon R
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference529 articles.
1. Aarsland D, Laake K, Larsen JP, Janvin C (2002). Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 72: 708–712.
2. Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K et al (2009). Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 8: 613–618.
3. Adams JR, van Netten H, Schulzer M, Mak E, McKenzie J, Strongosky A et al (2005). PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain 128: 2777–2785.
4. Adler CH (2008). Amantadine and anticholinergics. In: Factor SA, Weiner WJ (eds). Parkinson's Disease-Diagnostic and Clinical Management. Demos: New York. pp 491–497.
5. Agid Y (1998). Levodopa: is toxicity a myth? Neurology 50: 858–863.
Cited by
184 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献